|
Volumn 30, Issue 3, 2009, Pages 252-258
|
Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CONTRAST AGENT BR1;
CONTRAST MEDIUM;
DIAGNOSTIC AGENT;
PHOSPHOLIPID;
SULFUR HEXAFLUORIDE;
AGED;
ARTICLE;
CATHETER ABLATION;
COMPARATIVE STUDY;
COMPUTER ASSISTED SURGERY;
ECHOGRAPHY;
FEMALE;
FOLLOW UP;
HUMAN;
IMAGE ENHANCEMENT;
LIVER CELL CARCINOMA;
LIVER TUMOR;
MALE;
METHODOLOGY;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
POSTOPERATIVE COMPLICATION;
REOPERATION;
SPIRAL COMPUTER ASSISTED TOMOGRAPHY;
AGED;
CARCINOMA, HEPATOCELLULAR;
CATHETER ABLATION;
CONTRAST MEDIA;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMAGE ENHANCEMENT;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM, RESIDUAL;
PHOSPHOLIPIDS;
POSTOPERATIVE COMPLICATIONS;
REOPERATION;
SULFUR HEXAFLUORIDE;
SURGERY, COMPUTER-ASSISTED;
TOMOGRAPHY, SPIRAL COMPUTED;
ULTRASONOGRAPHY;
|
EID: 70349319836
PISSN: None
EISSN: 14388782
Source Type: Journal
DOI: 10.1055/s-2008-1027727 Document Type: Article |
Times cited : (45)
|
References (0)
|